The global bronchoscopes market size was valued at USD 873.0 million in 2024 and is projected to grow at a CAGR of 6.84% from 2025 to 2030. The rising incidences of respiratory disorders and growing awareness about early diagnosis are driving demand for bronchoscopes. Bronchoscopes are primarily used for the assessment and management of multiple respiratory and airway diseases. Conditions such as blockages, chronic obstructive pulmonary diseases (COPD), bronchopulmonary hemorrhage, tumors, airway stenosis, and inflammatory conditions can be detected and diagnosed through these devices.
The increasing incidence of respiratory conditions such as COPD, asthma, lung cancer, and emphysema worldwide are significant drivers for the bronchoscopy market. The World Health Organization (WHO) reports that COPD is the third leading cause of death worldwide, that led to 3.23 million deaths in 2019, with projections indicating it could become a major health threat by 2030. As the global population ages and environmental pollution worsens, the incidence of these conditions is expected to rise, with one in seven older adults suffering from lung conditions. This is expected to propel the demand for bronchoscopy procedures for diagnosis and treatment.
The field of bronchoscopy is evolving, with advancements in technology leading to the development of more precise, efficient, and safer bronchoscopes. For instance, recent innovations include virtual bronchoscopy, which utilizes 3D imaging to provide a more detailed view of the airways, and robotic bronchoscopes that offer improved maneuverability and control during procedures.
By product, the disposable segment dominated the market with a 49.0% revenue share in 2024 and is anticipated to witness a fastest CAGR growth over the forecast period. This is due to flexibility and convenience, which results in less discomfort during procedures. Disposable bronchoscopes eliminate the need for reprocessing, reducing turnaround time between procedures and allowing for faster patient care. Since they are single-use, they eliminate the risk of cross-contamination associated with reusable bronchoscopes, which is a major concern in healthcare facilities.
The flexible segment is anticipated to witness a significant CAGR growth over the forecast period. This is due to its thin and flexible design that allows easier navigation through the intricate bronchial airways, making it ideal for various diagnostic and therapeutic procedures. The superior imaging quality provided by flexible bronchoscopes is a key factor driving their increasing usage.
By end use, outpatient facilities dominated the market with a revenue share of 53.6% 2024 and is anticipated to witness a fastest CAGR growth over the forecast period. Advancements in technology have led to the development of portable and user-friendly bronchoscopes, making them suitable for outpatient settings where space may be limited. Moreover, the convenience and cost-effectiveness of performing bronchoscopy procedures in outpatient settings are driving healthcare providers to invest in these devices for their facilities.
The hospitals segment is anticipated to witness a significant CAGR growth over the forecast period. The increasing incidence rate of respiratory diseases globally, leading to a higher demand for diagnostic tools such as bronchoscopes in hospital settings. Furthermore, hospitals often have more resources and expertise available to perform complex bronchoscopy procedures, making them a preferred location.
North America bronchoscopes market dominated with 40.6% share in 2024 and is anticipated to witness a fastest CAGR growth over the forecast period. The North American market area is expected to grow over the forecast period due to high prevalence of chronic respiratory diseases such as COPD and lung cancer.
The U.S. bronchoscopes market dominated the North America market in 2024 due to a large patient pool with respiratory illnesses, which necessitates frequent diagnostic procedures. The presence of key market players in the country also contributes to the accessibility and availability of bronchoscopy devices, further propelling market growth. In the U.S., around 500,000 bronchoscopy procedures are currently conducted using either reusable flexible bronchoscopes or single-use flexible bronchoscopes.
Europe bronchoscopes market was identified as a lucrative region in 2024 due to as aging population and the risk of chronic respiratory diseases such as COPD. This necessitates more bronchoscopy procedures for diagnosis and treatment, propelling market growth. Diseases of the respiratory system accounted for 6.7 % of all deaths in the Europe in 2020. Over 1.5 million bronchoscopy procedures are performed each year across Europe. The UK bronchoscopes market is expected to grow rapidly in the coming years due to rising prevalence of respiratory diseases such as COPD and lung cancer.
Asia Pacific market is anticipated to witness significant growth in the coming years. This growth is due to the growing aging population in many countries in the region, which leading to an increase in respiratory disorders. Moreover, improving healthcare infrastructure and increasing healthcare expenditure in countries across the region are facilitating greater access to bronchoscopy procedures, thereby boosting market growth.
The bronchoscopes market in India held a substantial market share in 2023 due to several factors such as high burden of respiratory diseases and the increasing awareness about respiratory health and its early diagnosis.
Some of the key companies in the bronchoscopes market include Olympus Corporation, Ambu A/S, FUJIFILM Holdings Corporation, Boston Scientific Corporation, Richard Wolf GmbH, Broncus Medical, Inc. and others.
Ambu A/S specializes in developing, producing, and delivering innovative healthcare solutions in the fields of single-use endoscopy, anesthesia, and patient monitoring. Company’s Endoscopy Solutions portfolio includes high-performance single-use flexible endoscopes such as the Ambu aScope 4 Broncho. This product line offers sterile, convenient bronchoscopes for a wide range of medical procedures.
The following are the leading companies in the bronchoscopes market. These companies collectively hold the largest market share and dictate industry trends.
In May 2024, Olympus Corporation launched two bronchoscopes compatible with EVIS X1 Endoscopy System. The EVIS X1 Endoscopy System is the newest technology for diagnosing and treatment. Designed using advanced imaging, the two bronchoscopes provide doctors with a slim outer diameter in comparison to previous models.
In February 2023, FUJIFILM Holdings Corporation introduced the PB2020-M2, a compact ultrasonic probe system for bronchoscopy at BRONCHUS 2023. This new device allows for real-time imaging of lung lesions due to its small size and high-resolution ultrasound capabilities.
Report Attribute |
Details |
Market size value in 2025 |
USD 932.6 million |
Revenue forecast in 2030 |
USD 1.30 billion |
Growth rate |
CAGR of 6.84% from 2025 to 2030 |
Base year for estimation |
2024 |
Historical data |
2018 - 2023 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD billion and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, end use, region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Norway, Sweden, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait |
Key companies profiled |
Olympus Corporation, Ambu A/S, Teleflex Incorporated. , KARL STORZ SE & Co. KG, FUJIFILM Holdings Corporation, Boston Scientific Corporation, Richard Wolf GmbH, HOYA Corporation, Cook Medical , Broncus Medical, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the bronchoscopes market report based on product, end use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Rigid
Flexible
Disposable
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Mexico
Canada
Europe
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Thailand
Australia
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
b. The global bronchoscopes market size was estimated at USD 873.0 million in 2024 and is expected to reach USD 932.6 million in 2025.
b. The global bronchoscopes market is expected to grow at a compound annual growth rate of 6.84% from 2025 to 2030 to reach USD 1.30 billion by 2030.
b. Disposable bronchoscopes segment dominated the bronchoscopes market with a share of 49.0% in 2024. This is attributable to high video quality and significant cost effectiveness.
b. Some key players operating in the bronchoscopes market include Teleflex Incorporated; Olympus Corporation; Ambu A/s; Karl Storz; Fujifilm Holdings Corporation; Boston Scientific Corporation; and Cogentix Medical.
b. Key factors that are driving the market growth include increasing demand for bronchoscopes due to increasing prevalence of respiratory diseases, improving reimbursement policies, and technological advancements.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."